Bone Health in Patients with Adrenal Adenomas

Overview

About this study

The purpose of this study is to determine prevalence and incidence of osteopenia, osteoporosis, and fractures in patients with adenomas based on hormonal sub-type, and to determine the effect of abnormal steroid metabolome on bone density, bone metabolism, and fractures.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult ≥ 18 years old with adrenal adenoma, macro- or micronodular hyperplasia.
  • Available or planned dexamethasone suppression test result.
  • Ability to provide consent.

Exclusion Criteria: 

  • Individual < 18 years of age.
  • Inability to provide consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Irina Bancos, M.D.

Open for enrollment

Contact information:

Melinda Thomas B.S.

(507) 266-4761

Thomas.Melinda@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20517236

Mayo Clinic Footer